BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 3778614)

  • 1. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluctuations in quantitative features of intermediate cells in normal cervical smears during the menstrual cycle of ovulating women and contraceptive users.
    Kwikkel HJ; Boon ME; Rietvield WJ; Van Rijswijk M; Stolk JG
    Eur J Obstet Gynecol Reprod Biol; 1985 Feb; 19(2):89-95. PubMed ID: 3987954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the method of contraception.
    Vooijs GP; van der Graaf Y; Elias AG
    Acta Cytol; 1987; 31(4):417-26. PubMed ID: 3604536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive use and cervical intraepithelial neoplasia.
    Coker AL; McCann MF; Hulka BS; Walton LA
    J Clin Epidemiol; 1992 Oct; 45(10):1111-8. PubMed ID: 1474407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytologic observations of cervicovaginal smears during hormonal contraception].
    Ide P; Wijnants P; Bonte J
    Rev Cytol Clin; 1972; 5(3):105-12. PubMed ID: 12256654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
    McFarlane-Anderson N; Bazuaye PE; Jackson MD; Smikle M; Fletcher HM
    BMC Womens Health; 2008 May; 8():9. PubMed ID: 18513406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of quantitative features of visually normal intermediate cells in cervical intraepithelial neoplasia I and II smears to progression or nonprogression of the lesion.
    Kwikkel HJ; Timmers T; Boon ME; van Rijswijk MM; Stolk JG
    Anal Quant Cytol Histol; 1987 Oct; 9(5):405-10. PubMed ID: 3675799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrier methods of contraception and the risk of cervical neoplasia.
    Parazzini F; Negri E; La Vecchia C; Fedele L
    Contraception; 1989 Nov; 40(5):519-30. PubMed ID: 2692961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of endometrial cells in cervical smears in relation to the day of the menstrual cycle and the method of contraception.
    Vooijs GP; van der Graaf Y; Vooijs MA
    Acta Cytol; 1987; 31(4):427-33. PubMed ID: 3604537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives.
    Butterworth CE; Hatch KD; Gore H; Mueller H; Krumdieck CL
    Am J Clin Nutr; 1982 Jan; 35(1):73-82. PubMed ID: 7064879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antichlamydial activity of cervical secretion in different phases of the menstrual cycle and influence of hormonal contraceptives.
    Mahmoud EA; Hamad EE; Olsson SE; MĂ„rdh PA
    Contraception; 1994 Mar; 49(3):265-74. PubMed ID: 8200220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statistical approach to cervical and vaginal cytology during contraception].
    Fabiani B; Cava E; Marsan C
    Ann Pathol; 1983; 3(1):43-9. PubMed ID: 6838709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urea kinetics in healthy young women: minimal effect of stage of menstrual cycle, contraceptive pill and protein intake.
    McClelland IS; Jackson AA
    Br J Nutr; 1996 Aug; 76(2):199-209. PubMed ID: 8813895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cervical neoplasia diagnosis groups. Discriminant analysis on digitized cell images.
    Wheeler N; Suffin SC; Hall TL; Rosenthal DL
    Anal Quant Cytol Histol; 1987 May; 9(2):169-81. PubMed ID: 3606776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.